← back to search

Shashikant Kulkarni

The University of Texas MD Anderson Cancer Center · US
🔎 Find collaborators in Cancer Research · Hematology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Hematology
Research interest
Research interests include Cancer Genomics and Diagnostics, Genomics and Rare Diseases, Multiple Myeloma Research and Treatments, and Genetic factors in colorectal cancer.
h-index
35
citations
11,330
works
121
NIH funding
primary concept
email

Recent publications

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Genetics in Medicine 2022cited by 229position: middledoi
Best practices for the interpretation and reporting of clinical whole genome sequencing
npj Genomic Medicine 2022cited by 148position: middledoi
Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease
npj Genomic Medicine 2020cited by 150position: middledoi
Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA
Nature Medicine 2019cited by 261position: middledoi
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes
Human Mutation 2018cited by 66position: middledoi
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Journal of Molecular Diagnostics 2016cited by 1,981position: middledoi
Good laboratory practice for clinical next-generation sequencing informatics pipelines
Nature Biotechnology 2015cited by 155position: middledoi
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Nature 2012cited by 2,005position: middledoi
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
Cell 2012cited by 1,564position: middledoi
Assuring the quality of next-generation sequencing in clinical laboratory practice
Nature Biotechnology 2012cited by 468position: middledoi
Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data
Journal of Molecular Diagnostics 2012cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shimul Chowdhury · University of California System2 papers (2020–2022) · 2 papers (2020–2022)Eric J. Duncavage · Research Institute of Radiology2 papers (2012–2016)Ryan J. Taft · Genetic Alliance2 papers (2020–2022)John W. Belmont · Baylor College of Medicine2 papers (2020–2022)David Bick · Medical College of Wisconsin2 papers (2020–2022)Vaidehi Jobanputra · Columbia University2 papers (2020–2022)Haley Abel · James S. McDonnell Foundation1 papers (2012–2012)Michael Datto · Duke University1 papers (2016–2016)David H. Spencer · National Human Genome Research Institute1 papers (2012–2012)Niall J. Lennon · Broad Institute1 papers (2020–2020)Diana Mandelker · Ambry Genetics (United States)1 papers (2018–2018)Anas Younes · Intercept Pharmaceuticals (United States)1 papers (2016–2016)Eric Venner · Baylor College of Medicine1 papers (2022–2022) · 1 papers (2022–2022)Elizabeth Spiteri · Palo Alto University1 papers (2022–2022)Chimene Kesserwan · Center for Cancer Research1 papers (2018–2018)David R. Murdock · The University of Texas Health Science Center1 papers (2022–2022)Marilyn M. Li · Affiliated Hospital of Guizhou Medical University1 papers (2016–2016)Matthew S. Lebo · Color (United States)1 papers (2020–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Hematology →